Dr. Marty Makary

Maybe Charlie Kirk is on the college campus.

Maybe Charlie Kirk is on the college campus.

Well, thanks, Charlie. Great to see you and good to be with you. So politicians have been talking about this for a long time. And this is one of those common sense things that nobody has been willing to actually do. And this is what I love about President Trump. Here you have Americans paying 10, 12 or 15 times more for the same medication.

Well, thanks, Charlie. Great to see you and good to be with you. So politicians have been talking about this for a long time. And this is one of those common sense things that nobody has been willing to actually do. And this is what I love about President Trump. Here you have Americans paying 10, 12 or 15 times more for the same medication.

that Germans or British folks or people in France are getting at the lower price. And nobody has said, stop, wait a minute, what's going on here? By the way, sometimes these are American companies that are price gouging Americans as other wealthy nations get these sweetheart low prices. So the president has basically said no longer.

that Germans or British folks or people in France are getting at the lower price. And nobody has said, stop, wait a minute, what's going on here? By the way, sometimes these are American companies that are price gouging Americans as other wealthy nations get these sweetheart low prices. So the president has basically said no longer.

And he's not saying it as a, you know, looking for small incremental changes here. He wants dramatic changes to create a level playing field. He wants to make sure Americans can get the same most favored nation status price that these other countries are getting.

And he's not saying it as a, you know, looking for small incremental changes here. He wants dramatic changes to create a level playing field. He wants to make sure Americans can get the same most favored nation status price that these other countries are getting.

And I think you're going to see a real change in the price of these medications when you pick them up at the pharmacy and in the medical bill. Meaningful changes that are going to be pretty massive.

And I think you're going to see a real change in the price of these medications when you pick them up at the pharmacy and in the medical bill. Meaningful changes that are going to be pretty massive.

Yeah, good point. So most favored nation status is a declaration that Americans deserve the best price of a medication that is sold to wealthy countries, what we call OECD countries. So we're not saying we need the price that... Yeah, Ethiopia has or other poor countries. We're saying we want the price that wealthy nations get. They negotiate prices. They have a free market.

Yeah, good point. So most favored nation status is a declaration that Americans deserve the best price of a medication that is sold to wealthy countries, what we call OECD countries. So we're not saying we need the price that... Yeah, Ethiopia has or other poor countries. We're saying we want the price that wealthy nations get. They negotiate prices. They have a free market.

Why is the United States paying for all this R&D and upfront costs from basically price gouging Americans? Now, some will say that it will mean lower profits for pharma. Well, pharma has to figure out why they are charging such a lower price in other countries. They need to reconcile this massive disparity. And some might say that there might be less money for R&D. Well, I don't think so.

Why is the United States paying for all this R&D and upfront costs from basically price gouging Americans? Now, some will say that it will mean lower profits for pharma. Well, pharma has to figure out why they are charging such a lower price in other countries. They need to reconcile this massive disparity. And some might say that there might be less money for R&D. Well, I don't think so.

Pharma is pretty smart. They're going to create a level playing field because we are asking them to and we're doing it in a kind way. But we are also letting them know that we have the full regulatory authority of Medicare, of the Federal Trade Commission, of the trade representative, of the Department of Justice to ensure no monopoly pricing.

Pharma is pretty smart. They're going to create a level playing field because we are asking them to and we're doing it in a kind way. But we are also letting them know that we have the full regulatory authority of Medicare, of the Federal Trade Commission, of the trade representative, of the Department of Justice to ensure no monopoly pricing.

And even at FDA, we have good relationships with pharma, and we also have some carrots and sticks. So you're seeing an incredible coordinated effort come around now to try to bring this, to bring it home, and to actually make it happen. This is something politicians have talked about, but no one's made it happen.

And even at FDA, we have good relationships with pharma, and we also have some carrots and sticks. So you're seeing an incredible coordinated effort come around now to try to bring this, to bring it home, and to actually make it happen. This is something politicians have talked about, but no one's made it happen.

They've probably been worried about the pharma lobby, which is a massive lobby in Washington, D.C. I actually think when we see lower prices for Americans... you're going to see more access for lower income and minority communities. They have had a tough time paying high prices in the health care system across the board. Hospital bills, doctor's bills, drug prices.

They've probably been worried about the pharma lobby, which is a massive lobby in Washington, D.C. I actually think when we see lower prices for Americans... you're going to see more access for lower income and minority communities. They have had a tough time paying high prices in the health care system across the board. Hospital bills, doctor's bills, drug prices.